EPISODE · Mar 10, 2023 · 39 MIN
Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors
from Keeping Current CME
What's new in treatments for spondyloarthritis? Learn more about the rationale for novel therapies and the latest data. Credit available for this activity expires: 03/09/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/988291?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors
0:00
39:12
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 39 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 10, 2023.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!